Literature DB >> 24609648

Incidence of hypothyroidism and its correlation with polysomnography findings in obstructive sleep apnea.

K Murat Ozcan1, Adin Selcuk, Ibrahim Ozcan, Talih Ozdas, Fatih Ozdogan, Mustafa Acar, Huseyin Dere.   

Abstract

The aim of this study is to investigate the thyroid functions and its correlation with polysomnography findings in obstructive sleep apnea patients. This study was conducted on 203 patients evaluated with the complaints of snoring, witnessed apnea and daytime sleepiness and established polysomnography (PSG) indication between May 2008 and August 2011. All patients' nocturnal PSG recordings were carried out. The thyroid function was classified as euthyroid, subclinical hypothyroidism and clinical hypothyroidism after analyzing serum TSH and free T4 values. The correlation between the data obtained from PSG records and thyroid function values was statistically compared. Apnea hypopnea index obtained from PSG was in the range of 5.4-132.9/h, and mean value was 32.7/h. The lowest oxygen saturation level was in the range of 20-92 %, and the mean value was 76.4 %. According to PSG results, 55 patients (27.09 %) had mild obstructive sleep apnea syndrome (OSAS), 48 patients (23.65 %) had moderate OSAS and 100 patients (49.26 %) had severe OSAS. On evaluation of the thyroid function test results, 10.8 % (n = 22) of the patients were defined to have subclinical hypothyroidism and 1.97 % (n = 4) clinical hypothyroidism. We found a total of 12.77 % subclinical and clinical hypothyroidism in patients with OSAS. Though the incidence of hypothyroidism was pretty high in patients with OSA, there was no statistically significant correlation between thyroid functions and polysomnography findings. We suggest that evaluation of the thyroid functions is important and necessary in patients with OSAS. Polysomnography findings do not correlate statistically with thyroid function tests, addressing the need for thyroid screening for all OSAS patients.

Entities:  

Mesh:

Year:  2014        PMID: 24609648     DOI: 10.1007/s00405-014-2962-1

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  13 in total

1.  Influence of subclinical hypothyroidism and T4 treatment on the prevalence and severity of obstructive sleep apnoea syndrome (OSAS).

Authors:  O Resta; P Carratù; G E Carpagnano; M Maniscalco; G Di Gioia; D Lacedonia; R Giorgino; G De Pergola
Journal:  J Endocrinol Invest       Date:  2005-11       Impact factor: 4.256

2.  Neuroendocrine alterations in obese patients with sleep apnea syndrome.

Authors:  Fabio Lanfranco; Giovanna Motta; Marco Alessandro Minetto; Matteo Baldi; Marcella Balbo; Ezio Ghigo; Emanuela Arvat; Mauro Maccario
Journal:  Int J Endocrinol       Date:  2010-02-23       Impact factor: 3.257

3.  Thyroid testing and thyroid hormone replacement in patients with sleep disordered breathing.

Authors:  S A Mickelson; T Lian; L Rosenthal
Journal:  Ear Nose Throat J       Date:  1999-10       Impact factor: 1.697

4.  Screening for hypothyroidism in sleep apnea.

Authors:  N M Skjodt; R Atkar; P A Easton
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

5.  Prevalence of thyroid disease in patients with obstructive sleep apnea.

Authors:  Salman A Bahammam; Munir M Sharif; Anwar A Jammah; Ahmed S Bahammam
Journal:  Respir Med       Date:  2011-08-04       Impact factor: 3.415

Review 6.  The thyroid--too much and too little across the ages. The consequences of subclinical thyroid dysfunction.

Authors:  Jayne A Franklyn
Journal:  Clin Endocrinol (Oxf)       Date:  2013-01       Impact factor: 3.478

7.  Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

Authors:  Joseph G Hollowell; Norman W Staehling; W Dana Flanders; W Harry Hannon; Elaine W Gunter; Carole A Spencer; Lewis E Braverman
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

8.  Hypothyroid myopathy. A clinical and pathologaical study.

Authors:  R O McKeran; G Slavin; P Ward; E Paul; W G Mair
Journal:  J Pathol       Date:  1980-09       Impact factor: 7.996

9.  Sleep apnea, sleep disorders, and hypothyroidism.

Authors:  P VanDyck; R Chadband; B Chaudhary; M E Stachura
Journal:  Am J Med Sci       Date:  1989-08       Impact factor: 2.378

10.  Myxedema and obstructive sleep apnea.

Authors:  W C Orr; J L Males; N K Imes
Journal:  Am J Med       Date:  1981-05       Impact factor: 4.965

View more
  5 in total

1.  The effect of obstructive sleep apnea syndrome and hypothyroidism to intima-media thickness of carotid artery.

Authors:  Fulsen Bozkus; Nursel Dikmen; Gülay Güngör; Anıl Samur
Journal:  Sleep Breath       Date:  2016-07-20       Impact factor: 2.816

Review 2.  Impact of concomitant medications on obstructive sleep apnoea.

Authors:  Ingrid Jullian-Desayes; Bruno Revol; Elisa Chareyre; Philippe Camus; Céline Villier; Jean-Christian Borel; Jean-Louis Pepin; Marie Joyeux-Faure
Journal:  Br J Clin Pharmacol       Date:  2016-11-24       Impact factor: 4.335

3.  Clinical assessment and polysomnographic study of sleep apnea in a Chinese population of snorers.

Authors:  Chuan Shao; Jing-bo Jiang; Hong-cheng Wu; Shi-bo Wu; Bi-yun Yu; Yao-dong Tang
Journal:  J Zhejiang Univ Sci B       Date:  2015-03       Impact factor: 3.066

4.  Lack of associations between thyroid function and obstructive sleep apnea severity in adults with prediabetes and diabetes mellitus.

Authors:  Chutintorn Sriphrapradang; Sittichai Pinyopodjanard; Onnicha Suntornlohanakul; Hataikarn Nimitphong; Naricha Chirakalwasan; Sunee Saetang; Thunyarat Anothaisintawee; Nantaporn Siwasaranond; Areesa Manodpitipong; La-Or Chailurkit; Sirimon Reutrakul
Journal:  Sleep Breath       Date:  2018-11-19       Impact factor: 2.655

5.  The Course of Obstructive Sleep Apnea Syndrome in Patients With Acromegaly During Treatment.

Authors:  Thalijn L C Wolters; Sean H P P Roerink; Linda C A Drenthen; Jolanda H G M van Haren-Willems; Margaretha A E M Wagenmakers; Johannes W A Smit; Adrianus R M M Hermus; Romana T Netea-Maier
Journal:  J Clin Endocrinol Metab       Date:  2020-01-01       Impact factor: 5.958

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.